Belite Bio (BLTE) Accumulated Depreciation (2021 - 2025)

Belite Bio's Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $507000.0 for Q4 2025.

• On a quarterly basis, Accumulated Depreciation rose 48.68% year-over-year to $507000.0 in Q4 2025; TTM through Dec 2025 was $507000.0, a 48.68% increase from a year earlier, with the FY2025 full-year figure at $507000.0, up 48.68% from the prior year.
• Accumulated Depreciation climbed to $507000.0 in Q4 2025 per BLTE's latest filing, from $341000.0 in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $507000.0 in Q4 2025 and bottomed at $47000.0 in Q4 2021.
• The 5-year median for Accumulated Depreciation is $183000.0 (2023), against an average of $233800.0.
• Across the five-year window, Accumulated Depreciation soared 101.1% in 2023 and jumped 48.68% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $47000.0 in 2021, then surged by 93.62% to $91000.0 in 2022, then surged by 101.1% to $183000.0 in 2023, then jumped by 86.34% to $341000.0 in 2024, then soared by 48.68% to $507000.0 in 2025.
• Per Business Quant, the three latest BLTE Accumulated Depreciation figures stand at $507000.0 (Q4 2025), $341000.0 (Q4 2024), and $183000.0 (Q4 2023).